RE: Excellent and Risky OpportunityBioSante Pharmaceuticals seems to be a great opportunity if you're interested in investing in a biopharma. It is already in great financial position with no debt and tons of cash. If all goes well, the company is said to file for a new-drug application in late 2009 and launched by 2011.
Although it is risky since LibiGel has not yet been approved, it shows a lot of promise since it addresses a multibillion dollar market.